The immunometabolic ecosystem in cancer

Area of Science:

• Oncology
• Cancer Metabolism
• Tumor Microenvironment

Background:

• Cancer cells exploit unique metabolic pathways for survival and proliferation.
• Translating metabolic insights into effective clinical cancer therapies remains a significant challenge.
• The tumor microenvironment, including non-malignant cells, plays a crucial role in cancer progression.

Purpose of the Study:

• To review the metabolic interplay between cancer cells and non-malignant tumor-resident cells.
• To examine how targeting cancer metabolism can impact the tumor ecosystem.
• To highlight the need for a holistic approach in developing metabolism-targeted cancer therapies.

Main Methods:

• Review of current literature on cancer metabolism and tumor microenvironment.
• Analysis of metabolic crosstalk between malignant and non-malignant cells.
• Evaluation of the effects of metabolic inhibitors on tumor-resident cells and immune function.

Main Results:

• Targeting specific metabolic enzymes in cancer cells can have unintended consequences on non-malignant cells.
• Inhibition of cancer metabolism may promote tumor growth and create an immunosuppressive microenvironment.
• Metabolic interventions can impair the function of tumor-specific T cells.

Conclusions:

• A comprehensive understanding of the tumor's metabolic ecosystem is crucial for effective cancer treatment.
• Metabolism-targeted anticancer strategies must consider the broader impact on all tumor-resident cells.
• Holistic approaches are needed to improve the efficacy of drugs targeting cancer metabolism.